Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models

• Published in: Toxicology (Amsterdam) Vol. 221; no. 2; pp. 241 - 248
• Main Author: Hack, C. Eric
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier Ireland Ltd 17-04-2006
• Subjects: Animals; Bayes Theorem; Bayesian; Humans; Markov Chains; MCMC; Models, Biological; Monte Carlo Method; PBPK; PBTK; Pharmacokinetics; Pharmacology - statistics & numerical data; Physiology - statistics & numerical data; Toxicology - statistics & numerical data; MCMC; PBPK; PBTK; Bayesian
• ISSN: 0300-483X; 1879-3185
• DOI: 10.1016/j.tox.2005.12.017

Physiologically based toxicokinetic (PBTK) and toxicodynamic (TD) models of bromate in animals and humans would improve our ability to accurately estimate the toxic doses in humans based on available animal studies. These mathematical models are often highly parameterized and must be calibrated in order for the model predictions of internal dose to adequately fit the experimentally measured doses. Highly parameterized models are difficult to calibrate and it is difficult to obtain accurate estimates of uncertainty or variability in model parameters with commonly used frequentist calibration methods, such as maximum likelihood estimation (MLE) or least squared error approaches. The Bayesian approach called Markov chain Monte Carlo (MCMC) analysis can be used to successfully calibrate these complex models. Prior knowledge about the biological system and associated model parameters is easily incorporated in this approach in the form of prior parameter distributions, and the distributions are refined or updated using experimental data to generate posterior distributions of parameter estimates. The goal of this paper is to give the non-mathematician a brief description of the Bayesian approach and Markov chain Monte Carlo analysis, how this technique is used in risk assessment, and the issues associated with this approach.